SOX11 and mantle cell lymphoma: In this study, we show for the first time that V-ATPase inhibitors effectively reduce proliferation in MCL cells, are sensitive to SOX11 status and that V-ATPase is expressed on the surface of both primary MCL cells and cell lines, and thus an interesting therapeutic target.